Health
Alpha-ray missile therapy: Tumor cells attacked from intracellular region – Medical Xpress
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor…
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor effects, but there has been limited progress in the development of radionuclide therapy agents targeting LAT1. Now, a multidisciplinary research team at Osaka University has established a targeted alpha-therapy with a novel drug targeting LAT1.
The researchers first produced the alpha-ray emitter 211Astatine, no easy task given that Astatine…
-
Business23 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
Noosa News23 hours agoThe small patch of paddock emitting 10,000 cars’ worth of methane
-
Business23 hours agoGuess which ASX 200 stock is rocketing on big US news
-
Noosa News23 hours agoBrisbane City Council to tap private sector for Riverstage upgrade